Indacrinone calcium | CAS# 108260-88-4 | Biochemical

MedKoo Cat#: 576658 | Name: Indacrinone calcium

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Indacrinone calcium is a loop diuretic.

Chemical Structure

Indacrinone calcium

CAS#108260-88-4

Theoretical Analysis

MedKoo Cat#: 576658

Name: Indacrinone calcium

CAS#: 108260-88-4

Chemical Formula: C36H26CaCl4O8

Exact Mass: 766.0008

Molecular Weight: 768.47

Elemental Analysis: C, 56.27; H, 3.41; Ca, 5.22; Cl, 18.45; O, 16.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Indacrinone calcium

IUPAC/Chemical Name

Acetic acid, 2-((6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-2-phenyl-1H-inden-5-yl)oxy)-, calcium salt (2:1)

InChi Key

ODXDBZSKOODCSR-UHFFFAOYSA-L

InChi Code

InChI=1S/2C18H14Cl2O4.Ca/c2*1-18(11-5-3-2-4-6-11)8-10-7-12(24-9-13(21)22)15(19)16(20)14(10)17(18)23;/h2*2-7H,8-9H2,1H3,(H,21,22);/q;;+2/p-2

SMILES Code

[Ca+2].CC1(Cc2cc(OCC(=O)[O-])c(Cl)c(Cl)c2C1=O)c3ccccc3.CC4(Cc5cc(OCC(=O)[O-])c(Cl)c(Cl)c5C4=O)c6ccccc6

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 768.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Rybak LP, Whitworth C, Morris C, Scott V, Kanno H. Cochlear effects of indacrinone are not altered by penicillin. Hear Res. 1995 May;85(1-2):122-6. PubMed PMID: 7559168. 2: Beaujean V, Crabbé J. Conductive chloride flux across amphibian skin: inhibition by indacrinone and cobalt ion. Biochim Biophys Acta. 1992 Feb 17;1104(1):174-8. PubMed PMID: 1550845. 3: Takagi S, Takayama S, Onodera T. Hepatotoxicity of DR-3438, tienilic acid, indacrinone and furosemide studied in vitro. Toxicol Lett. 1991 Mar;55(3):287-93. PubMed PMID: 2003271. 4: Hanna GM, Lau-Cam CA. Determination of the optical purity of indacrinone by proton nuclear magnetic resonance spectroscopy using chiral lanthanide chelates. J Pharm Biomed Anal. 1989;7(8):919-28. PubMed PMID: 2562290. 5: Rybak LP, Whitworth C. Ototoxicity of indacrinone is stereospecific. Hear Res. 1987 Dec;31(2):169-74. PubMed PMID: 3446673. 6: Vyas KP, Hichens M, Mulcahy WS, Hand EL. Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolites. J Immunoassay. 1987;8(2-3):179-201. PubMed PMID: 3624493. 7: Dürr JE, Larsen EH. Indacrinone (MK-196)--a specific inhibitor of the voltage-dependent Cl- permeability in toad skin. Acta Physiol Scand. 1986 Jun;127(2):145-53. PubMed PMID: 3088914. 8: Hatzis A, Rothchild R. Optical purity determination and (1)H-NMR spectral simplification with lanthanide shift reagents - VIII. An indacrinone precursor, 6,7-dichloro-5-methoxy-2-methyl-2-phenyl-1-indanone. J Pharm Biomed Anal. 1986;4(4):443-9. PubMed PMID: 16867580. 9: Nagel W, Beauwens R, Crabbé J. Opposite effects of indacrinone (MK-196) on sodium and chloride conductance of amphibian skin. Pflugers Arch. 1985 Apr;403(4):337-43. PubMed PMID: 3925431. 10: Jain AK, Michael R, Ryan JR, McMahon FG. Antihypertensive and biochemical effects of indacrinone enantiomers. Pharmacotherapy. 1984 Sep-Oct;4(5):278-83. PubMed PMID: 6504709. 11: Vlasses PH, Rotmensch HH, Swanson BN, Irvin JD, Johnson CL, Ferguson RK. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men. Pharmacotherapy. 1984 Sep-Oct;4(5):272-7. PubMed PMID: 6504708. 12: Field MJ, Fowler N, Giebisch GH. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo. J Pharmacol Exp Ther. 1984 Jul;230(1):62-8. PubMed PMID: 6747832. 13: Brooks BA, Lant AF, McNabb WR, Noormohamed FH. Renal actions of a uricosuric diuretic, racemic indacrinone, in man: comparison with ethacrynic acid and hydrochlorothiazide. Br J Clin Pharmacol. 1984 May;17(5):497-512. PubMed PMID: 6428442; PubMed Central PMCID: PMC1463457. 14: Brooks BA, Lant AF, McNabb WR, Noormohamed FH. Stereo-specificity of diuretic receptors in the nephron: a study of the enantiomers of indacrinone (MK-196) in man. Ren Physiol. 1984;7(5):304-10. PubMed PMID: 6484299. 15: Blaine EH, Fanelli GM Jr, Irvin JD, Tobert JA, Davies RO. Enantiomers of indacrinone: a new approach to producing an isouricemic diuretic. Clin Exp Hypertens A. 1982;4(1-2):161-76. PubMed PMID: 7074983. 16: Zacchei AG, Dobrinska MR, Wishousky TI, Kwan KC, White SD. Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys. Drug Metab Dispos. 1982 Jan-Feb;10(1):20-7. PubMed PMID: 6124378. 17: Robertson RT, Minsker DH, Bokelman DL, Durand G, Conquet P. Potassium loss as a causative factor for skeletal malformations in rats produced by indacrinone: a new investigational loop diuretic. Toxicol Appl Pharmacol. 1981 Aug;60(1):142-50. PubMed PMID: 7281172. 18: Vlasses PH, Irvin JD, Huber PB, Lee RB, Ferguson RK, Schrogie JJ, Zacchei AG, Davies RO, Abrams WB. Pharmacology of enantiomers and (-) p-OH metabolite of indacrinone. Clin Pharmacol Ther. 1981 Jun;29(6):798-807. PubMed PMID: 7226712. 19: Tobert JA, Cirillo VJ, Hitzenberger G, James I, Pryor J, Cook T, Buntinx A, Holmes IB, Lutterbeck PM. Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio. Clin Pharmacol Ther. 1981 Mar;29(3):344-50. PubMed PMID: 7471605. 20: Brooks BA, Blair EM, Finch R, Lant AF. Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196). Br J Clin Pharmacol. 1980 Sep;10(3):249-58. PubMed PMID: 7437242; PubMed Central PMCID: PMC1430055. 6